Literature DB >> 8688260

Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome.

A J Pittard1, R E Banks, H F Galley, N R Webster.   

Abstract

We have assessed the role of the cell-cell adhesion molecule, E-cadherin, in the pathogenesis of multiorgan failure in 24 intensive care patients with sepsis and varying degrees of organ dysfunction, compared with 21 healthy subjects. Plasma soluble E-cadherin (sE-cadherin) was measured by enzyme immunoassay. The median concentration of sE-cadherin in normal subjects was 3.21 micrograms ml-1 compared with 6.00 micrograms ml-1 in patients with sepsis and organ dysfunction (P = 0.0019). There was no statistically significant difference in concentrations of sE-cadherin in survivors compared with non-survivors. Concentrations of sE-cadherin tended to increase with the severity of organ failure. We conclude that sE-cadherin is increased in inflammation and injury, and may be related to the degree of multiorgan failure after sepsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688260     DOI: 10.1093/bja/76.5.629

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.

Authors:  A O Chan; S K Lam; K M Chu; C M Lam; E Kwok; S Y Leung; S T Yuen; S Y Law; W M Hui; K C Lai; C Y Wong; H C Hu; C L Lai; J Wong
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  E-cadherin in gastric cancer.

Authors:  Annie On On Chan
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

3.  Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions.

Authors:  Hendrik Streeck; Douglas S Kwon; Augustine Pyo; Michael Flanders; Mathieu F Chevalier; Kenneth Law; Boris Jülg; Kasper Trocha; Jonathan S Jolin; Melis N Anahtar; Jeff Lian; Ildiko Toth; Zabrina Brumme; J Judy Chang; Tyler Caron; Scott J Rodig; Danny A Milner; Alicja Piechoka-Trocha; Daniel E Kaufmann; Bruce D Walker; Marcus Altfeld
Journal:  Blood       Date:  2011-03-14       Impact factor: 22.113

Review 4.  Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling.

Authors:  Andrew P Kowalczyk; Benjamin A Nanes
Journal:  Subcell Biochem       Date:  2012

Review 5.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

6.  Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.

Authors:  Sabine M Brouxhon; Stephanos Kyrkanides; Xiaofei Teng; M Kerry O'Banion; Robert Clarke; Stephen Byers; Li Ma
Journal:  Mol Carcinog       Date:  2013-06-18       Impact factor: 4.784

7.  Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients.

Authors:  C Wilmanns; J Grossmann; S Steinhauer; G Manthey; B Weinhold; A Schmitt-Gräff; B U von Specht
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 8.  Soluble E-cadherin: more than a symptom of disease.

Authors:  Magdalena M Grabowska; Mark L Day
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report.

Authors:  Joanna Giebultowicz; Malgorzata Polanska-Plachta; Piotr Wroczynski; Piotr Zaborowski; Jerzy A Polanski
Journal:  Diagn Pathol       Date:  2012-02-18       Impact factor: 2.644

10.  Soluble E-cadherin: an early marker of severity in acute pancreatitis.

Authors:  A Sewpaul; J J French; T K Khoo; M Kernohan; J A Kirby; R M Charnley
Journal:  HPB Surg       Date:  2009-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.